He was accompanied by Mr. Andrew Patrick, British High Commissioner, Ms. Anna Shotbolt, Deputy Trade Commissioner, South Asia, Ms. Mara Waters, Director of Trade, Sri Lanka, Ms. Asanthi Fernando, Deputy Head of Trade & Investment and Ms. Shameema Yusuf, UK Trade Envoy Relationship Manager, APAC & South Asia.
The visit provided Haleon Sri Lanka with a unique opportunity to showcase current initiatives and ambitious future plans aimed at fostering innovation and driving economic development.
The delegation was taken through a comprehensive tour of Haleon's Liquid and Tablet manufacturing facilities, highlighting its impressive legacy and operations.
The unit not only delivers quality healthcare to Sri Lankans but also exports to other markets globally.
The Ratmalana manufacturing facility stands as a testament to Haleon's enduring commitment to delivering better everyday health with humanity.
Chanaka Wanniarachchi, Managing Director, Sri Lanka & Maldives, Haleon Lanka,
“Since 1956, Haleon has contributed to providing high-quality medicines that meet global standards, while investing in the development of Sri Lanka’s pharmaceutical workforce.
As an industry leader, we are proud to have created meaningful employment, transferred critical skills, and helped strengthen the country’s healthcare ecosystem.
Our efforts support a healthier and more skilled nation, as well as further deepen the longstanding UK–Sri Lanka partnership in pharmaceutical technology and healthcare innovation.”
Andrew Patrick, British High Commissioner to Sri Lanka,
“It was a pleasure to visit Haleon’s Ratmalana facility and witness the remarkable contribution it continues to make to Sri Lanka’s healthcare sector.
This site not only reflects the strength of the UK–Sri Lanka trade and investment partnership but also highlights the value of long-standing British businesses in empowering local talent, advancing innovation, and supporting sustainable economic development.”
The Haleon Sri Lanka facility, part of the global consumer healthcare company Haleon UK (erstwhile GlaxoSmithKline Consumer Health), has been proudly managed by Sri Lankans since 1956, and is dedicated to improving the health and well-being of consumers.
Haleon's extensive portfolio includes well-known brands such as Sensodyne, Panadol, ENO, Iodex, Corsodyl, Voltaren and Piriton that help millions of Sri Lankans live healthier lives.
Sensodyne provides effective relief from tooth sensitivity, allowing individuals to enjoy their favorite foods and drinks without discomfort.
Panadol offers fast and effective pain relief, while ENO helps with quick relief from acidity and indigestion.
Iodex provides targeted relief for muscle pain, and Corsodyl supports gum health.
Voltaren is known for its powerful anti-inflammatory properties, Together, these trusted brands contribute to the overall well-being and health of the community.
About Haleon
Haleon (LSE/NYSE: HLN) is a global leader in consumer health, with a purpose to deliver better everyday health with humanity.
Haleon's product portfolio spans six major categories - Oral Health, Vitamins, Minerals and Supplements (VMS), Pain Relief, Respiratory Health, Digestive Health and Therapeutic Skin Health and Other.
Its long-standing brands are built on trusted science, innovation and deep human understanding.
Photo caption : Haleon Senior Leadership Team Hosts UK Delegation